Log In
BCIQ
Print this Print this
 

Sucraid

  Manage Alerts
Collapse Summary General Information
Company QOL Medical LLC
DescriptionSacrosidase enzyme replacement therapy
Molecular Target
Mechanism of ActionEnzyme replacement therapy
Therapeutic ModalityBiologic: Enzyme
Latest Stage of DevelopmentMarketed
Standard Indication Metabolic (unspecified)
Indication DetailsTreat congenital sucrase-isomaltase deficiency (CSID)
Regulatory Designation
Partner

 Product Details
 Archive Items are loading loading
Collapse Summary Deals Information
 Deals Details
Get a free BioCentury trial today